Drug Type Small molecule drug |
Synonyms Roxithromycin And Ambroxol Hydrochloride, 罗红霉素/盐酸氨溴索 |
Target |
Mechanism SCNA blockers(Sodium channel alpha subunit blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CN (15 Jan 2010), |
Regulation- |
Molecular FormulaC13H19Br2ClN2O |
InChIKeyQNVKOSLOVOTXKF-PFWPSKEQSA-N |
CAS Registry23828-92-4 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Bronchitis, Chronic | CN | 15 Jan 2010 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Respiratory Tract Infections | Phase 2 | CN | - |